1.14.20.13	(1R,2R,4S,5S,7s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane	slight inhibition by the substrate analogue	89457	
1.14.20.13	1-methylpiperidin-4-yl 2-phenylacetate	-	192681	
1.14.20.13	3,4-dihydroxybenzoate	competitive inhibitor with respect to 2-oxoglutarate	736	
1.14.20.13	6,7-Dehydrohyoscyamine	-	29621	
1.14.20.13	8-methyl-8-azabicyclo[3.2.1]octan-3-yl 2-(4-(dimethylamino)phenyl)acetate	-	175469	
1.14.20.13	8-methyl-8-azabicyclo[3.2.1]octan-3-yl 3-phenylpropanoate	-	193168	
1.14.20.13	8-methyl-8-azabicyclo[3.2.1]octan-3-yl benzoate	-	175470	
1.14.20.13	8-oxabicyclo[3.2.1]octan-3-yl 2-phenylacetate	-	193169	
1.14.20.13	Ca2+	5 mM, 100% inhibition	15	
1.14.20.13	Cd2+	0.4 mM, 100% inhibition	52